(In the Media) ‘Regenerative Medicine: Promoting prompt review in Japan’ (Nippon Keizai Shimbun, December 5, 2014) (In Japanese)
date : 12/5/2014
HGPI’s
Toshio Miyata provides his views on the Act Concerning Safety Assurance
on Regenerative Medicine, which became effective on November 26, 2014.
The aim of this act is to spread regenerative medicine promptly and
safely.
Top Research & Recommendations Posts
- [Research Report] The Public Opinion Survey on Cancer Genomics and Precision Medicine (March 9, 2022)
- [Recommendations] Proposal on a Global Procurement System for Coronavirus Disease 2019 (COVID-19) Vaccines (September 7, 2020)
- [Policy Recommendations] Furthering the Development of Precision Cancer Medicine —Proposals for Effective Policy Changes Based on Key Characteristics of Precision Medicine in Cancer Treatment— (September 20, 2022)
- [Announcement] HGPI Planetary Health Policy Team Signs Healthy Climate Prescription (August 31, 2022)
- [Joint Report and Recommendations] “Rebalancing Health System: Innovation and Sustainability” A Joint Global Expert Meeting convened by the CSIS and HGPI
